Literature DB >> 19201863

Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.

Erika D Reynoso1, Kutlu G Elpek, Loise Francisco, Roderick Bronson, Angélique Bellemare-Pelletier, Arlene H Sharpe, Gordon J Freeman, Shannon J Turley.   

Abstract

The B7 family member programmed death-1 ligand (PD-L1) has been shown to play an inhibitory role in the regulation of T cell responses in several organs. However, the role of PD-L1 in regulating tolerance to self-Ags of the small intestine has not been previously addressed. In this study, we investigated the role of PD-L1 in CD8(+) T cell tolerance to an intestinal epithelium-specific Ag using the iFABP-tOVA transgenic mouse model, in which OVA is expressed as a self-Ag throughout the small intestine. Using adoptive transfer of naive OVA-specific CD8(+) T cells, we show that loss of PD-1:PD-L1 signaling, by either Ab-mediated PD-L1 blockade or transfer of PD-1(-/-) T cells, leads to considerable expansion of OVA-specific CD8(+) T cells and their differentiation into effector cells capable of producing proinflammatory cytokines. A fatal CD8(+) T cell-mediated inflammatory response develops rapidly against the small bowel causing destruction of the epithelial barrier, severe blunting of intestinal villi, and recruitment and activation of myeloid cells. This response is highly specific because immune destruction selectively targets the small intestine but not other organs. Collectively, these results indicate that loss of the PD-1:PD-L1 inhibitory pathway breaks CD8(+) T cell tolerance to intestinal self-Ag, thus leading to severe enteric autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201863      PMCID: PMC3682217          DOI: 10.4049/jimmunol.0802769

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction.

Authors:  V Vezys; S Olson; L Lefrançois
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

Review 2.  Cross-presentation, dendritic cells, tolerance and immunity.

Authors:  W R Heath; F R Carbone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 3.  Man the barrier! Strategic defences in the intestinal mucosa.

Authors:  C Nagler-Anderson
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

4.  Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

Authors:  Masayoshi Ishida; Yoshiko Iwai; Yoshimasa Tanaka; Taku Okazaki; Gordon J Freeman; Nagahiro Minato; Tasuku Honjo
Journal:  Immunol Lett       Date:  2002-10-21       Impact factor: 3.685

5.  Expression of programmed death 1 ligands by murine T cells and APC.

Authors:  Tomohide Yamazaki; Hisaya Akiba; Hideyuki Iwai; Hironori Matsuda; Mami Aoki; Yuka Tanno; Tahiro Shin; Haruo Tsuchiya; Drew M Pardoll; Ko Okumura; Miyuki Azuma; Hideo Yagita
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

6.  Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells.

Authors:  Michael J Eppihimer; Jason Gunn; Gordon J Freeman; Edward A Greenfield; Tetyana Chernova; Jamie Erickson; John P Leonard
Journal:  Microcirculation       Date:  2002-04       Impact factor: 2.628

7.  Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.

Authors:  Julia A Brown; David M Dorfman; Feng-Rong Ma; Elizabeth L Sullivan; Oliver Munoz; Clive R Wood; Edward A Greenfield; Gordon J Freeman
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

8.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

9.  A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes.

Authors:  F P Huang; N Platt; M Wykes; J R Major; T J Powell; C D Jenkins; G G MacPherson
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens.

Authors:  Gabrielle T Belz; Georg M N Behrens; Chris M Smith; Jacques F A P Miller; Claerwen Jones; Kristina Lejon; C Garrison Fathman; Scott N Mueller; Ken Shortman; Francis R Carbone; William R Heath
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more
  59 in total

1.  BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction.

Authors:  Nicholas J Shubin; Chun S Chung; Daithi S Heffernan; Lydea R Irwin; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2012-03-29       Impact factor: 4.962

2.  B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance.

Authors:  Jang-June Park; Ryusuke Omiya; Yumiko Matsumura; Yukimi Sakoda; Atsuo Kuramasu; Mathew M Augustine; Sheng Yao; Fumihiko Tsushima; Hidehiko Narazaki; Sudarshan Anand; Yingjia Liu; Scott E Strome; Lieping Chen; Koji Tamada
Journal:  Blood       Date:  2010-05-14       Impact factor: 22.113

3.  PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance.

Authors:  Joanne E Konkel; Friederike Frommer; Melanie D Leech; Hideo Yagita; Ari Waisman; Stephen M Anderton
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

Review 4.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors:  Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

5.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.

Authors:  Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

6.  Tissue-expressed B7-H1 critically controls intestinal inflammation.

Authors:  Lisa Scandiuzzi; Kaya Ghosh; Kimberly A Hofmeyer; Yael M Abadi; Eszter Lázár-Molnár; Elaine Y Lin; Qiang Liu; Hyungjun Jeon; Steven C Almo; Lieping Chen; Stanley G Nathenson; Xingxing Zang
Journal:  Cell Rep       Date:  2014-02-13       Impact factor: 9.423

7.  Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.

Authors:  Kristen E Pauken; Christine E Nelson; Tijana Martinov; Vaiva Vezys; Brian T Fife; Justin A Spanier; James R Heffernan; Nathanael L Sahli; Clare F Quarnstrom; Kevin C Osum; Jason M Schenkel; Marc K Jenkins; Bruce R Blazar
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

8.  Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation.

Authors:  Sun-Young Chang; Joo-Hye Song; Bayasi Guleng; Carmen Alonso Cotoner; Seiji Arihiro; Yun Zhao; Hao-Sen Chiang; Michael O'Keeffe; Gongxian Liao; Christopher L Karp; Mi-Na Kweon; Arlene H Sharpe; Atul Bhan; Cox Terhorst; Hans-Christian Reinecker
Journal:  Immunity       Date:  2012-12-13       Impact factor: 31.745

Review 9.  Biochemical signaling of PD-1 on T cells and its functional implications.

Authors:  Vassiliki A Boussiotis; Pranam Chatterjee; Lequn Li
Journal:  Cancer J       Date:  2014 Jul-Aug       Impact factor: 3.360

Review 10.  AIRE in the thymus and beyond.

Authors:  James M Gardner; Anne L Fletcher; Mark S Anderson; Shannon J Turley
Journal:  Curr Opin Immunol       Date:  2009-10-14       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.